Ovarian Neoplasms Concept

subject area of

• A CASE OF MASCULINIZING OVARIAN TUMOR: USE OF CORTICOSTEROID INHIBITION TEST IN DIAGNOSIS  Academic Article
• A Comparison of Two Prophylactic Regimens for Hypersensitivity Reactions to Paclitaxel  Academic Article
• A New Series of Succinimido-ferrociphenols and Related Heterocyclic Species Induce Strong Antiproliferative Effects, Especially against Ovarian Cancer Cells Resistant to Cisplatin  Academic Article
• A Randomized Trial of Paracentesis plus Intraperitoneal Tumor Necrosis Factor-α versus Paracentesis Alone in Patients with Symptomatic Ascites from Recurrent Ovarian Carcinoma  Academic Article
• A case control study of carcinoma of the ovary.  Academic Article
• A novel approach identifies new differentially methylated regions (DMRs) associated with imprinted genes  Academic Article
• A phase II study of single-agent RO4929097, a gamma-secretase inhibitor of Notch signaling, in patients with recurrent platinum-resistant epithelial ovarian cancer: A study of the Princess Margaret, Chicago and California phase II consortia  Academic Article
• A predictive index of cure versus no cure in advanced ovarian carcinoma patients—Replacement of second-look laparotomy as a diagnostic test  Academic Article
• A prime/boost vaccine platform efficiently identifies CD27 agonism and depletion of myeloid-derived suppressor cells as therapies that rationally combine with checkpoint blockade in ovarian cancer  Academic Article
• A rapid and simple method for the purification of tumor cells from ascitic fluid of ovarian carcinoma  Academic Article
• A systematic review of patient values, preferences and expectations for the treatment of recurrent ovarian cancer  Academic Article
• A unique BRCA1 mutation identified in Mongolia  Academic Article
• AAV-mediated expression of 3TSR inhibits tumor and metastatic lesion development and extends survival in a murine model of epithelial ovarian carcinoma  Academic Article
• ABT-510 induces tumor cell apoptosis and inhibits ovarian tumor growth in an orthotopic, syngeneic model of epithelial ovarian cancer  Academic Article
• ABT-898 Induces Tumor Regression and Prolongs Survival in a Mouse Model of Epithelial Ovarian Cancer  Academic Article
• ACR Appropriateness Criteria® Clinically Suspected Adnexal Mass, No Acute Symptoms  Academic Article
• Acoustic streaming cannot discriminate reliably between endometriomas and other types of adnexal lesion: a multicenter study of 633 adnexal masses  Academic Article
• Adrenal metastasis from ovarian carcinoma  Academic Article
• Adriamycin and cisplatin in the treatment of stage III and IV epithelial ovarian carcinoma  Academic Article
• Advanced Ovarian Cancer: Phase III Randomized Study of Sequential Cisplatin–Topotecan and Carboplatin–Paclitaxel vs Carboplatin–Paclitaxel  Academic Article
• Akt isoform specific effects in ovarian cancer progression  Academic Article
• An Endodermal Sinus Tumor Diagnosed in Pregnancy: Case Report and Review of the Literature  Academic Article
• An Ontario Health (Cancer Care Ontario) Clinical Practice Guideline: Consolidation or Maintenance Systemic Therapy for Newly Diagnosed Stage II, III, or IV Epithelial Ovary, Fallopian Tube, or Primary Peritoneal Carcinoma  Academic Article
• Autocrine VEGF-A/KDR loop protects epithelial ovarian carcinoma cells from anoikis  Academic Article
• Autoimmune haemolytic anaemia associated with ovarian dermoid cyst  Academic Article
• Bilateral Lymphangiomas of the Ovary  Academic Article
• Body mass index in relation to ovarian cancer: A multi-centre nested case-control study  Academic Article
• Breast and ovarian cancer risk perception after prophylactic salpingo-oophorectomy due to an inherited mutation in theBRCA1orBRCA2gene  Academic Article
• Breastfeeding and the risk of epithelial ovarian cancer among women with a BRCA1 or BRCA2 mutation  Academic Article
• Cancer health effects of pesticides: systematic review.  Academic Article
• Carboplatin and pegylated liposomal doxorubicin versus carboplatin and paclitaxel in partially platinum-sensitive ovarian cancer patients: results from a subset analysis of the CALYPSO phase III trial  Academic Article
• Carboplatin hypersensitivity presenting as coronary vasospasm - a case report  Academic Article
• Care Delivery Patterns, Processes, and Outcomes for Primary Ovarian Cancer Surgery: A Population-Based Review Using a National Administrative Database  Academic Article
• Cell Junctions in Lymphomas: Study of a Primary Ovarian T-Cell Lymphoma and Review of Fifty-Six Other Cases of Lymphoma  Academic Article
• Challenges in Experimental Modeling of Ovarian Cancerogenesis  Academic Article
• Chemotherapy for recurrent epithelial ovarian cancer previously treated with platinum--a systematic review of the evidence from randomized trials.  Academic Article
• Chemotherapy of advanced ovarian carcinoma: Initial experience using a platinum-based combination  Academic Article
• Choices of Methodology in Pharmacoeconomic Studies  Academic Article
• Circulating Inflammation Markers and Risk of Epithelial Ovarian Cancer  Academic Article
• Circulating levels of insulin-like growth factor-I and risk of ovarian cancer  Academic Article
• Circulating levels of sex steroid hormones and risk of ovarian cancer  Academic Article
• Circulating prolactin levels and risk of epithelial ovarian cancer  Academic Article
• Circulating soluble Fas levels and risk of ovarian cancer  Academic Article
• Clinical Management Recommendations for Surveillance and Risk-Reduction Strategies for Hereditary Breast and Ovarian Cancer Among Individuals Carrying a Deleterious BRCA1 or BRCA2 Mutation  Academic Article
• Combined therapy with thrombospondin‐1 type I repeats (3TSR) and chemotherapy induces regression and significandy improves survival in a preclinical model of advanced stage epithelial ovarian cancer  Academic Article
• Combining Vascular Normalization with an Oncolytic Virus Enhances Immunotherapy in a Preclinical Model of Advanced-Stage Ovarian Cancer  Academic Article
• Complications of whole abdominal and pelvic radiotherapy following chemotherapy for advanced ovarian cancer  Academic Article
• Consolidation or maintenance systemic therapy for newly diagnosed stage II, III, or IV epithelial ovary, fallopian tube, or primary peritoneal carcinoma: A systematic review  Academic Article
• Cytokine elevations in acute coronary syndrome and ovarian cancer: A mechanism for the up-regulation of the acute phase proteins in these different disease etiologies  Academic Article
• DEVELOPMENT OF ANTI-IDIOTYPIC ANTIBODIES AGAINST TUMOUR ANTIGENS AND AUTOANTIGENS IN OVARIAN CANCER PATIENTS TREATED INTRAPERITONEALLY WITH MOUSE MONOCLONAL ANTIBODIES  Academic Article
• Dalteparin Low Molecular Weight Heparin (LMWH) in ovarian cancer: A phase II randomized study  Academic Article
• Desmoplastic Small Round Cell Tumor (DSRCT) With Ovarian Involvement in 2 Young Women  Academic Article
• Desmoplastic small round cell tumor presenting in the ovaries: Report of a case and review of the literature  Academic Article
• Diagnosing endometriosis: CA125 rules in, but not out  Academic Article
• Dietary Risk Factors for Ovarian Cancer: The Adventist Health Study (United States)  Academic Article
• Do Deeper Sections Increase the Frequency of Detection of Serous Tubal Intraepithelial Carcinoma (STIC) in the “Sectioning and Extensively Examining the FIMbriated End” (SEE-FIM) Protocol?  Academic Article
• Early stage ovarian cancer: a randomized clinical trial comparing whole abdominal radiotherapy, melphalan, and intraperitoneal chromic phosphate: a National Cancer Institute of Canada Clinical Trials Group report.  Academic Article
• Economic and policy implications of adopting paclitaxel as first-line therapy for advanced ovarian cancer: an Ontario perspective.  Academic Article
• Ectopic production of prostate specific antigen by a breast tumor metastatic to the ovary  Academic Article
• Effect of radiation and other cytotoxic agents on the growth of cells cultured from normal and tumor tissues from the female genital tract  Academic Article
• Effectiveness of the Risk of Malignancy Index and the Risk of Ovarian Malignancy Algorithm in a Cohort of Women With Ovarian Cancer  Academic Article
• Endodermal Sinus Tumor in Pregnancy  Academic Article
• Endometrioid Cystadenofibroma of the Ovary with Pelvic Lymph Node Involvement  Academic Article
• Endometriosis-Associated Ovarian Carcinomas  Academic Article
• Endometriosis: Diagnosis and Management  Academic Article
• Energetic characteristics of cisplatin resistant ovarian carcinoma cells.  Academic Article
• Epithelial–stromal interaction increases cell proliferation, survival and tumorigenicity in a mouse model of human epithelial ovarian cancer  Academic Article
• Establishment and characterization of four human epithelial ovarian carcinoma cell lines  Academic Article
• Ets-1 Regulates Energy Metabolism in Cancer Cells  Academic Article
• Ets-1 regulates intracellular glutathione levels: key target for resistant ovarian cancer  Academic Article
• Evidence for a dose-response effect between p53 (but not p21WAF1/Cip1) protein concentrations, survival, and responsiveness in patients with epithelial ovarian cancer treated with platinum-based chemotherapy.  Conference Paper
• Ex vivo-expanded NK cells from blood and ascites of ovarian cancer patients are cytotoxic against autologous primary ovarian cancer cells  Academic Article
• Exon 5 of the p53 gene is a target for deletions in ovarian cancer  Academic Article
• Expanded CD56superbrightCD16+ NK Cells from Ovarian Cancer Patients Are Cytotoxic against Autologous Tumor in a Patient-Derived Xenograft Murine Model  Academic Article
• Expression of Metallothionein and Nuclear Size in Discrimination of Malignancy in Mucinous Ovarian Tumors  Academic Article
• Expression of the prostate-specific antigen gene by a primary ovarian carcinoma.  Academic Article
• FDA ovarian cancer clinical trial endpoints workshop: A Society of Gynecologic Oncology White Paper  Academic Article
• Factors determining the ability of cytokine-activated killer cells to lyse human ovarian carcinoma targets  Academic Article
• Familial ovarian cancer.  Academic Article
• Fertility considerations in the gynecologic oncology patient.  Academic Article
• Follicular Variant Papillary Thyroid Carcinoma Arising in Struma Ovarii  Academic Article
• Foreign Body Reaction Mimicking Breast Carcinoma in Patient with Stage IV Ovarian Cancer  Academic Article
• Frequency of Serous Tubal Intraepithelial Carcinoma in Various Gynecologic Malignancies  Academic Article
• Generation of lymphokine-activated killer cells in human ovarian carcinoma ascitic fluid: Identification of transforming growth factor-β as a suppressive factor  Academic Article
• Genetics Consultation Rates Following a Diagnosis of High-Grade Serous Ovarian Carcinoma in the Canadian Province of Ontario  Academic Article
• Getting to the heart of the problem: a case report on the use of emergency department ultrasonography in a patient with shortness of breath.  Academic Article
• Guideline No. 403: Initial Investigation and Management of Adnexal Masses  Academic Article
• Health care use and risk of ovarian cancer: Is there a link?  Academic Article
• Hormone Replacement Therapy After Oophorectomy and Breast Cancer Risk Among BRCA1 Mutation Carriers  Academic Article
• How oncologists communicate information to women with recurrent ovarian cancer in the context of treatment decision making in the medical encounter  Academic Article
• Human ovarian cancer ascites fluid contains a mixture of incompletely degraded soluble products of fibrin that collectively possess an antiangiogenic property  Academic Article
• Human ovarian carcinoma: evidence for patient-related differences in susceptibility to cytotoxic effectors that attack different cellular subpopulations within a tumour  Academic Article
• Hyperglycemia promotes insulin-independent ovarian tumor growth  Academic Article
• IGFBP-3 in epithelial ovarian carcinoma and its association with clinico-pathological features and patient survival  Academic Article
• Ifosfamide and mesna in combination with other cytostatic drugs in the treatment of patients with advanced cancer  Academic Article
• Ignored Because It Is Benign – It Is Time to Treat Endometriosis as if It Were Cancer  Academic Article
• Immunofluorometric assay of p53 protein versus sequencing of p53 exons 5 to 9 for the detection of p53 abnormalities in ovarian carcinoma.  Academic Article
• Immunohistochemical localization of tyrosine receptor kinases A and B in endometriosis-associated ovarian cancer  Academic Article
• Incorporating patient centered benefits as endpoints in randomized trials of maintenance therapies in advanced ovarian cancer: A position paper from the GCIG symptom benefit committee  Academic Article
• Individual and family characteristics associated with protein truncating BRCA1 and BRCA2 mutations in an Ontario population based series from the Cooperative Family Registry for Breast Cancer Studies  Academic Article
• Influence of the proto-oncogene c-fos on cisplatin sensitivity  Academic Article
• International Gynecologic Cancer Society (IGCS 2012)  Academic Article
• Interobserver Agreement for Mismatch Repair Protein Immunohistochemistry in Endometrial and Nonserous, Nonmucinous Ovarian Carcinomas  Conference Paper
• Intraperitoneal chemotherapy in the first-line treatment of women with stage III epithelial ovarian cancer  Academic Article
• Is Uterine Papillary Serous Adenocarcinoma a Manifestation of the Hereditary Breast–Ovarian Cancer Syndrome?  Academic Article
• Is incidental prophylactic oophorectomy an acceptable means to reduce the incidence of ovarian cancer?  Academic Article
• It's a choice to move forward: women's perceptions about treatment decision making in recurrent ovarian cancer  Academic Article
• Jnk1 activity lowers the cellular production of H2O2 and modulates the growth arrest response to scavenging of H2O2 by catalase  Academic Article
• Kaiso regulates Znf131-mediated transcriptional activation  Academic Article
• Low-grade serous carcinoma (LGSC): A Canadian multicenter review of practice patterns and patient outcomes  Conference Paper
• Malignant Ascites Fluid (MAF), Including Ovarian-Cancer-Associated MAF, Contains Angiostatin and Other Factor(s) Which Inhibit Angiogenesis  Academic Article
• Malignant Transformation Within Ovarian Dermoid Cysts  Academic Article
• Mehrfachtumoren beim Korpuskarzinom  Academic Article
• Metallothionein expression and nuclear size in benign, borderline, and malignant serous ovarian tumours  Academic Article
• Metastatic Ovarian Carcinoma of Large Intestinal Origin Simulating Primary Ovarian Carcinoma: A Clinicopathologic Study of 25 Cases  Academic Article
• Mitochondrial membrane potential regulation is independent of c-fos expression  Academic Article
• Molecular Imaging and Precision Medicine in Uterine and Ovarian Cancers  Academic Article
• Mutant p53 protein overexpression is associated with poor outcome in patients with well or moderately differentiated ovarian carcinoma  Academic Article
• Neoadjuvant and adjuvant systemic therapy for newly diagnosed stage II- IV epithelial ovary, fallopian tube, or primary peritoneal carcinoma: A systematic review  Academic Article
• Neoadjuvant chemotherapy versus debulking surgery in advanced tubo-ovarian cancers: pooled analysis of individual patient data from the EORTC 55971 and CHORUS trials  Academic Article
• Nucleotide excision repair in the human ovarian carcinoma cell line (2008) and its cisplatin-resistant variant (C13*)  Academic Article
• Objective Responses in Patients with Malignant Melanoma or Renal Cell Cancer in Early Clinical Studies Do Not Predict Regulatory Approval  Academic Article
• Oncologists’ Perceptions of Recurrent Ovarian Cancer Patients’ Preference for Participation in Treatment Decision Making and Strategies for When and How to Involve Patients in This Process  Academic Article
• Oncolytic Maraba virus armed with tumor antigen boosts vaccine priming and reveals diverse therapeutic response patterns when combined with checkpoint blockade in ovarian cancer  Academic Article
• Orthotopic, syngeneic mouse model to study the effects of epithelial-stromal interaction  Academic Article
• Outcomes for systemic therapy in women with ovarian cancer  Academic Article
• Outcomes in Surgery for Ovarian Cancer  Academic Article
• Ovarian cancer in elderly patients: carboplatin and pegylated liposomal doxorubicin versus carboplatin and paclitaxel in late relapse: a Gynecologic Cancer Intergroup (GCIG) CALYPSO sub-study  Academic Article
• Ovarian tumour growth is characterized by mevalonate pathway gene signature in an orthotopic, syngeneic model of epithelial ovarian cancer  Academic Article
• Patients’ Preferences for Therapy in Advanced Epithelial Ovarian Cancer: Development, Testing, and Application of a Bedside Decision Instrument  Academic Article
• Patterns of care in the initial management of women with ovarian cancer in Ontario.  Academic Article
• Performance characteristics of screening strategies to identify Lynch syndrome in women with ovarian cancer  Academic Article
• Phase I Clinical Trial of Recombinant Human Interleukin-3 Combined With Carboplatin in the Treatment of Patients With Recurrent Ovarian Carcinoma  Academic Article
• Phase I trial of UCN-01 in combination with topotecan in patients with advanced solid cancers: a Princess Margaret Hospital Phase II Consortium study  Academic Article
• Phase I trial of gemcitabine, doxorubicin and cisplatin (GAP) in patients with advanced solid tumors  Academic Article
• Phase II clinical trial of carboplatin and docetaxel in patients with metastatic ovarian cancer: Active combination with low incidence of peripheral neuropathy  Academic Article
• Phase II study of CGP 69846A (ISIS 5132) in recurrent epithelial ovarian cancer: an NCIC clinical trials group study (NCIC IND.116)☆  Academic Article
• Phase II study of mitomycin C and 5 fluorouracil in platinum resistant ovarian cancer.  Academic Article
• Phosphorylation switches Bax from promoting to inhibiting apoptosis thereby increasing drug resistance  Academic Article
• Physicians' attitudes, beliefs and knowledge concerning ovarian cancer.  Academic Article
• Pleural Effusion Detected at CT prior to Primary Cytoreduction for Stage III or IV Ovarian Carcinoma: Effect on Survival  Academic Article
• Preoperative identification of a suspicious adnexal mass: A systematic review and meta-analysis  Academic Article
• Pro-apoptotic and anti-angiogenic actions of 2-methoxyestradiol and docosahexaenoic acid, the biologically derived active compounds from flaxseed diet, in preventing ovarian cancer  Academic Article
• Proceedings of the Second NCI–SNMMI Workshop on Targeted Radionuclide Therapy  Academic Article
• Prognostic Significance of Supradiaphragmatic Lymphadenopathy Identified on Preoperative Computed Tomography Scan in Patients Undergoing Primary Cytoreduction for Advanced Epithelial Ovarian Cancer  Academic Article
• Prognostic factors for women with Stage 1 ovarian cancer with or without adhesions.  Academic Article
• Prophylactic oophorectomy in Ontario.  Academic Article
• Prostate-Specific antigen expression by various tumors  Academic Article
• Quality of life and psychosexual adjustment after prophylactic oophorectomy for a family history of ovarian cancer.  Academic Article
• Reciprocal cellular cross-talk within the tumor microenvironment promotes oncolytic virus activity  Academic Article
• Recurrent Ovarian Cancer: Use of Contrast-enhanced CT and PET/CT to Accurately Localize Tumor Recurrence and to Predict Patients’ Survival  Academic Article
• Reversal of suppression of lymphokine-activated killer cells by transforming growth factor-β in ovarian carcinoma ascitic fluid requires interleukin-2 combined with anti-CD3 antibody  Academic Article
• Risk factors for ovarian cancer and early-onset breast cancer in Mongolia.  Academic Article
• Risk of ovarian cancer in relation to prediagnostic levels of C-peptide, insulin-like growth factor binding proteins-1 and -2 (USA, Sweden, Italy).  Academic Article
• Risks and benefits of screening asymptomatic women for ovarian cancer: A systematic review and meta-analysis  Academic Article
• Role of the transcription factor Ets-1 in cisplatin resistance.  Academic Article
• Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial  Academic Article
• Safety and Efficacy of Patupilone in Patients With Advanced Ovarian, Primary Fallopian, or Primary Peritoneal Cancer: A Phase I, Open-Label, Dose-Escalation Study  Academic Article
• Screening Postmenopausal Women for Ovarian Cancer: A Systematic Review  Academic Article
• Second-line chemotherapy of stage III-IV ovarian carcinoma: a randomized comparison of melphalan to melphalan and hexamethylmelamine in patients with persistent disease after doxorubicin and cisplatin.  Academic Article
• Selecting a BRCA risk assessment model for use in a familial cancer clinic  Academic Article
• Sertoliform Endometrioid Carcinoma of the Ovary: A Potential Diagnostic Pitfall  Academic Article
• Serum follicle-stimulating hormone and risk of epithelial ovarian cancer in postmenopausal women.  Academic Article
• Solitary fibrous tumor (SFT) of the pelvis  Academic Article
• Sorafenib in Combination With Gemcitabine in Recurrent Epithelial Ovarian Cancer: A Study of the Princess Margaret Hospital Phase II Consortium  Academic Article
• Squamous Lesions of the Ovary  Academic Article
• Standard chemotherapy with or without bevacizumab in advanced ovarian cancer: quality-of-life outcomes from the International Collaboration on Ovarian Neoplasms (ICON7) phase 3 randomised trial  Academic Article
• Stop, Think, and Re-evaluate: A Decidualized Endometrioma can Mimic Malignancy in Pregnancy  Academic Article
• Subacute cor pulmonale due to tumor embolization.  Academic Article
• Surgery as sole treatment for serous borderline tumors of the ovary with noninvasive implants  Academic Article
• Surgical management of a suspicious adnexal mass: A systematic review  Academic Article
• Surgical outcomes in women with ovarian cancer.  Academic Article
• Synthesis, characterization, structure, molecular modeling studies and biological activity of sterically crowded Pt(II) complexes containing bis(imidazole) ligands  Academic Article
• Systematic review of adjuvant care for women with Stage I ovarian carcinoma  Academic Article
• Targeting endothelin 1 receptor-miR-200b/c-ZEB1 circuitry blunts metastatic progression in ovarian cancer  Academic Article
• Telomerase activity associated with acquisition of malignancy in human colorectal cancer.  Academic Article
• Telomerase activity in human ovarian carcinoma.  Academic Article
• Temporal trends in the relative survival among patients diagnosed with ovarian cancer in Canada 1992–2005: A population-based study  Academic Article
• The Cancer-associated K351N Mutation Affects the Ubiquitination and the Translocation to Mitochondria of p53 Protein  Academic Article
• The Fallopian Tube as the Origin of High Grade Serous Ovarian Cancer: Review of a Paradigm Shift  Academic Article
• The Meaning-Making intervention (MMi) appears to increase meaning in life in advanced ovarian cancer: a randomized controlled pilot study  Academic Article
• The Quality of the Operative Report for Women With Ovarian Cancer in Ontario  Academic Article
• The Thrombospondin-1 Mimetic ABT-510 Increases the Uptake and Effectiveness of Cisplatin and Paclitaxel in a Mouse Model of Epithelial Ovarian Cancer  Academic Article
• The association between smoking and cancer incidence in BRCA1 and BRCA2 mutation carriers  Academic Article
• The chemotherapy of granulosa cell tumors of the ovary: Experience of the wisconsin clinical cancer center  Academic Article
• The impact of prophylactic salpingo-oophorectomy on menopausal symptoms and sexual function in women who carry a BRCA mutation  Academic Article
• The impact of prophylactic salpingo-oophorectomy on quality of life and psychological distress in women with a BRCA mutation  Academic Article
• The impact of the ovarian microenvironment on the anti-tumor effect of SPARC on ovarian cancer1This article is part of Special Issue entitled Asilomar Chromatin and has undergone the Journal’s usual peer review process.  Academic Article
• Transforming Growth Factor α Localization and Role in Surface Epithelium of Normal Human Ovaries and in Ovarian Carcinoma Cells  Academic Article
• Treatment of clitoromegaly of culturally diverse patients  Academic Article
• Treatment of early epithelial ovarian cancer with chemotherapy and abdominopelvic radiotherapy: results of a prospective treatment protocol  Conference Paper
• Treatment of infertility does not increase the risk of ovarian cancer among women with a BRCA1 or BRCA2 mutation  Academic Article
• Tumor site discordance in mismatch repair deficiency in synchronous endometrial and ovarian cancers  Academic Article
• Two Phase I Studies of Carboplatin Dose Escalation in Chemotherapy-Naive Ovarian Cancer Patients Supported With Patients Supported With Granulocyte-Macrophage Colony-Stimulating Factor  Academic Article
• UCN-01 in combination with topotecan in patients with advanced recurrent ovarian cancer: A study of the Princess Margaret Hospital Phase II consortium  Academic Article
• Use of systemic therapy in women with recurrent ovarian cancer—Development of a national clinical practice guideline  Academic Article
• VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agents  Academic Article
• Walking a tightrope: oncologists’ perspective on providing information to women with recurrent ovarian cancer (ROC) during the medical encounter  Academic Article
• Women’s perceptions about treatment decision making for ovarian cancer  Academic Article
• [Pseudotumor aspect of ovarian vein thrombosis].  Academic Article
• [Risk of ovarian cancer in women treated for infertility].  Academic Article
• [Risk of ovarian cancer in women treated for infertility].  Academic Article
• cAMP response element–binding protein is expressed at high levels in human ovarian adenocarcinoma and regulates ovarian tumor cell proliferation  Academic Article
• ets‐1is transcriptionally up‐regulated by H2O2via an antioxidant response element  Academic Article
• hMENA is a key regulator in endothelin-1/β-arrestin1–induced invadopodial function and metastatic process  Academic Article
• miR-30a inhibits endothelin A receptor and chemoresistance in ovarian carcinoma  Academic Article
• β-arrestin1/YAP/mutant p53 complexes orchestrate the endothelin A receptor signaling in high-grade serous ovarian cancer  Academic Article